Mathes Company’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $582K | Sell |
11,770
-4,800
| -29% | -$244K | 0.18% | 81 |
|
|
2026
Q1 | $884K | Hold |
16,570
| – | – | 0.32% | 59 |
|
|
2025
Q4 | $1.03M | Hold |
16,570
| – | – | 0.37% | 54 |
|
|
2025
Q3 | $996K | Hold |
16,570
| – | – | 0.36% | 54 |
|
|
2025
Q2 | $1.04M | Hold |
16,570
| – | – | 0.39% | 56 |
|
|
2025
Q1 | $997K | Buy |
16,570
+70
| +0.4% | +$4.35K | 0.41% | 55 |
|
|
2024
Q4 | $963K | Sell |
16,500
-34,200
| -67% | -$2.03M | 0.35% | 57 |
|
|
2024
Q3 | $3M | Hold |
50,700
| – | – | 1.06% | 34 |
|
|
2024
Q2 | $2.84M | Hold |
50,700
| – | – | 1.03% | 33 |
|
|
2024
Q1 | $2.97M | Hold |
50,700
| – | – | 1.11% | 33 |
|
|
2023
Q4 | $2.74M | Hold |
50,700
| – | – | 1.13% | 34 |
|
|
2023
Q3 | $2.46M | Sell |
50,700
-600
| -1% | -$31.9K | 1.14% | 34 |
|
|
2023
Q2 | $2.9M | Buy |
+51,300
| New | +$2.83M | 1.27% | 28 |
|
|
2022
Q4 | $2.73M | Hold |
51,900
| – | – | 1.38% | 31 |
|
|
2022
Q3 | $2.45M | Hold |
51,900
| – | – | 1.37% | 27 |
|
|
2022
Q2 | $2.62M | Hold |
51,900
| – | – | 1.27% | 30 |
|
|
2022
Q1 | $3.16M | Hold |
51,900
| – | – | 1.23% | 34 |
|
|
2021
Q4 | $3.42M | Sell |
51,900
-840
| -2% | -$53.8K | 1.17% | 36 |
|
|
2021
Q3 | $3.31M | Hold |
52,740
| – | – | 1.23% | 33 |
|
|
2021
Q2 | $3.17M | Hold |
52,740
| – | – | 1.14% | 38 |
|
|
2021
Q1 | $2.9M | Sell |
52,740
-4,560
| -8% | -$253K | 1.12% | 40 |
|
|
2020
Q4 | $3.13M | Hold |
57,300
| – | – | 1.27% | 33 |
|
|
2020
Q3 | $2.86M | Hold |
57,300
| – | – | 1.33% | 29 |
|
|
2020
Q2 | $2.53M | Hold |
57,300
| – | – | 1.26% | 31 |
|
|
2020
Q1 | $2.15M | Sell |
57,300
-90
| -0.2% | -$3.79K | 1.43% | 29 |
|
|
2019
Q4 | $2.53M | Buy |
57,390
+1,800
| +3% | +$75.7K | 1.18% | 37 |
|
|
2019
Q3 | $2.29M | Buy |
55,590
+6,600
| +13% | +$270K | 1.18% | 38 |
|
|
2019
Q2 | $1.97M | Hold |
48,990
| – | – | 1.04% | 38 |
|
|
2019
Q1 | $1.89M | Hold |
48,990
| – | – | 0.96% | 42 |
|
|
2018
Q4 | $1.63M | Sell |
48,990
-1,800
| -4% | -$62.3K | 1.03% | 38 |
|
|
2018
Q3 | $1.93M | Buy |
50,790
+4,800
| +10% | +$171K | 0.9% | 40 |
|
|
2018
Q2 | $1.54M | Buy |
45,990
+1,500
| +3% | +$48.9K | 0.73% | 45 |
|
|
2018
Q1 | $1.37M | Buy |
44,490
+1,200
| +3% | +$37K | 0.64% | 49 |
|
|
2017
Q4 | $1.25M | Hold |
43,290
| – | – | 0.57% | 50 |
|
|
2017
Q3 | $1.21M | Buy |
43,290
+19,200
| +80% | +$531K | 0.57% | 54 |
|
|
2017
Q2 | $669K | Buy |
+24,090
| New | +$638K | 0.32% | 76 |
|
Other funds holding IHI
AAS
Mathes Company's IHI Position: Q2 2026 in Review
Mathes Company reduced its iShares US Medical Devices ETF (IHI) stake by 29% in Q2 2026, selling an estimated $244K and leaving 11,770 shares worth $582K. The position accounts for 0.18% of the portfolio, ranked #81.
Mathes Company first reported a position in IHI in Q2 2017 and has held it in 36 quarters since. The position peaked at $3.42M in Q4 2021. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- Mathes Company held 11,770 shares of iShares US Medical Devices ETF worth $582K as of Q2 2026.
- Mathes Company sold 4,800 iShares US Medical Devices ETF shares in Q2 2026, an estimated $244K.
- iShares US Medical Devices ETF made up 0.18% of Mathes Company's portfolio in Q2 2026, its #81 holding.
- Mathes Company first reported a position in iShares US Medical Devices ETF in Q2 2017 and has held it in 36 quarters since.
- Mathes Company's iShares US Medical Devices ETF position peaked at $3.42M in Q4 2021.
- 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on Mathes Company's 13F filing for Q2 2026, filed 11 Aug 2026.